openPR Logo
Press release

Cardiovascular & Soft Tissue Repair Patch Market Analysis and Outlook Report

10-17-2022 07:16 AM CET | Health & Medicine

Press release from: Transparency Market Research

Cardiovascular & Soft Tissue Repair Patch Market: Introduction

Transparency Market Research has published a new report titled, "Global Cardiovascular & Soft Tissue Repair Patch Market". According to the report, the global cardiovascular & soft tissue repair patch market was valued at US$ 1.9 Bn in 2018 and is projected to expand at a CAGR of ~10% from 2019 to 2027. Cardiovascular & soft tissue repair patches can be synthetic or biologic. Biologic patches can be classified into allogenic (made of donor human tissue) and xenogeneic (porcine or bovine in origin).

Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=75903

Adoption of Minimally Invasive Therapies to Address Rise in Prevalence of Cardiovascular & Soft Tissue Anomalies to Drive Global Market
Inclination toward minimally invasive procedures and rise in prevalence of atrial & ventricular septal defects and acquired cardiovascular & soft tissue anomalies are anticipated to fuel the growth of the global cardiovascular & soft tissue repair patch market. High prevalence of congenital and acquired anomalies in cardiovascular & soft tissues such as septal defects and hernia is expected to drive demand for cardiovascular & soft tissue repair patches. Increase in health care expenditure and reimbursements are likely to augment the global market.

Get Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75903

Biologic Patch to Dominate Cardiovascular & Soft Tissue Repair Patch Market

In terms of product, the biologic patch segment accounted for major share of the global cardiovascular & soft tissue repair patch market in 2018. The segment is projected to dominate the global market during the forecast period. Cardiovascular patch is used by surgeons at the end of open heart surgery for the treatment of ventricular septal defects, atrial septal defects, etc. Hence, reconstruction of defects, revascularization, and patch closure are required. Increase in number of patients with congenital heart defects leads to rise in demand for patches. According to the Centers for Disease Control and Prevention, an estimated 2,118 babies were born with atrial septal defect in the U.S. in 2019.

Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=75903

Soft Tissue Repair to Witness Strong Demand

In terms of application, the soft tissue repair segment accounted for major share of the global cardiovascular & soft tissue repair patch market in 2018. The segment is anticipated to grow at a rapid pace during the forecast period. The hernia repair sub-segment of the soft tissue repair segment is expected to expand at a high CAGR from 2019 to 2027. Rise in number of hernia repair procedures increases demand for biologics. For instance, hernia repair is one of the most common surgeries performed across the globe. In the U.S., more than 350,000 ventral hernia repairs are performed each year.

According to Visceral Medicine, inguinal hernia repair is the most commonly performed surgical procedure across the globe, with an estimated 20 million patients annually. An article published in NCBI stated that hernia repair is a common surgery and around 800,000 inguinal hernia repairs are performed in the U.S. every year.

Enquiry Before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=75903

Rise in Number of Cardiovascular and Soft Tissue Repair Surgeries in Hospitals to Lead Global Market

Based on end user, the hospitals segment accounted for major share of the global cardiovascular & soft tissue repair patch market in 2018. The segment is likely to grow at a rapid pace during the forecast period. Increase in the geriatric population and rise in the number of cardiovascular and soft tissue repair surgeries are anticipated to drive the segment. The number of people aged 80 and over is projected to increase from 143 million in 2019 to 426 million by 2050.

Get Table of Content of the Report @ https://www.transparencymarketresearch.com/cardiovascular-soft-tissue-repair-patch-market.html#tableOfContent

Cardiovascular & Soft Tissue Repair Patch Market: Prominent Regions

North America held the largest share of the global cardiovascular & soft tissue repair patch market in 2018. The cardiovascular & soft tissue repair patch market in the region is likely to grow at a rapid pace during the forecast period. The cardiovascular & soft tissue repair patch market in the region is driven by the presence of key players, large number of research activities, and highly structured healthcare industry.

Strategies adopted by the key players such as product approval & launch and rise in number of patients with congenital heart defects are anticipated to fuel the growth of the cardiovascular & soft tissue repair patch market in the region. The U.S. is projected to dominate the cardiovascular & soft tissue repair patch market in North America during the forecast period. The country is anticipated to be the most attractive market for cardiovascular & soft tissue repair patches, with high attractiveness index. The cardiovascular & soft tissue repair patch market in the U.S. is likely to expand at a CAGR of 9.8% during the forecast period.

CorPATCh received the U.S. Food and Drug Administration approval in June 2019 for pericardial tissue repair and support in adult patients. According to the National Organization for Rare Disorders, Inc., atrial septal defect is more common in women than men in the U.S. and nearly 1% of all babies are born with congenital heart defect.

Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=75903

Cardiovascular & Soft Tissue Repair Patch Market: Key Players

Key players focus on strengthening their positions in the global cardiovascular & soft tissue repair patch market. Strategies adopted by key players are likely to boost the growth of the global cardiovascular & soft tissue repair patch market. These players engage in collaboration, acquisition, and other strategies to strengthen their positions in the global cardiovascular & soft tissue repair patch market. South America Implants S.A. and Minimal Medics Co. entered into a strategic distribution agreement in September 2018 to expand internationally. Baxter International, Inc. received CE mark approval for Hemopatch in March 2016. It is used to close dural defects.

Major players operating in the global cardiovascular & soft tissue repair patch market include W. L. Gore & Associates, Inc., BD, Edwards Lifesciences Corporation, CryoLife, Inc., Baxter International, Inc., Johnson & Johnson (Medical Devices Business Services, Inc.), Aesculap, Inc. (a B. Braun company), Nurami Medical Nanofiber Technology, Medtronic, FOC Medical S.A., Medprin Regenerative Medical Technologies Co., Ltd., CorMatrix, Inc., Terumo Corporation, Lamed GmbH, and South America Implants S.A.

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiovascular & Soft Tissue Repair Patch Market Analysis and Outlook Report here

News-ID: 2768951 • Views:

More Releases from Transparency Market Research

Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive AI Adoption and Next-Generation Edge Computing Innovations | TMR
Neuromorphic Chip Market to Reach USD 2.3 Billion by 2034, Driven by Explosive A …
The global Neuromorphic Chip Market is entering a defining phase of exponential growth, propelled by a surge in artificial intelligence (AI) applications, edge computing expansion, and rapid advancements in next-generation semiconductor technologies. According to the latest industry analysis, the market-valued at US$ 56.2 Mn in 2023-is projected to expand at an extraordinary CAGR of 40.1% from 2024 to 2034, reaching an estimated US$ 2.3 Bn by 2034. Examine key highlights and
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological Disease Burden Accelerates | TMR
Neuroprotection Market Surges Toward USD 60.1 Bn by 2031 as Global Neurological …
The global Neuroprotection Market continues to gain unprecedented momentum as healthcare systems worldwide intensify their focus on combating neurological disorders. With a valuation of US$ 31.6 Bn in 2022, the market is on track to reach US$ 60.1 Bn by 2031, expanding at a robust 7.5% CAGR during the forecast period. The rise in dementia, stroke, Parkinson's, epilepsy, and multiple sclerosis-combined with aging demographics and a surge in sedentary lifestyles-has
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Innovations in Gene Editing, Stem Cell Therapy, and AI-Based Neuromedicine | TMR
Neuroregeneration Therapy Market Set to Reach USD 64.8 Bn by 2034, Driven by Inn …
The global neuroregeneration therapy market continues to chart steady, sustained growth. The increasing incidence of neurological disorders-including Alzheimer's disease, Parkinson's disease, multiple sclerosis, Huntington's disease, stroke, diabetic neuropathy, and spinal cord injuries-is significantly influencing market expansion. In 2023, the market was worth US$ 37.0 Bn, demonstrating rising demand for treatments capable of repairing or regenerating damaged neural tissue. Examine key highlights and takeaways from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86322 With breakthroughs
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Advances in Brain Mapping, AI, and Portable Neuroimaging | TMR
Neuroscience Market Set to Reach USD 41.6 Bn by 2031 Driven by Technological Adv …
The global neuroscience market stood at US$ 30.1 Bn in 2022, reflecting the significant technological and clinical potential of neurological research. Projected to grow at a CAGR of 3.7% from 2023 to 2031, the industry is expected to reach US$ 41.6 Bn by 2031. Rising prevalence of neurodegenerative diseases, advancements in neuroimaging, integration of artificial intelligence, and the emergence of brain-computer interfaces are shaping the next decade of neuroscience innovation. Examine

All 5 Releases


More Releases for Cardiovascular

Cardiovascular Medical Lasers: A Leading Driver Behind Rising Cardiovascular Dis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Cardiovascular Medical Lasers Industry Market Size Be by 2025? The market size for cardiovascular medical lasers has experienced substantial growth of late. From 2024 to 2025, the market is projected to expand from $0.31 billion to $0.44 billion, with a compound annual growth rate (CAGR) of
Rising Cardiovascular Diseases Drive Demand For Cardiovascular Medical Lasers Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Cardiovascular Medical Lasers Market Size By 2025? In recent times, there has been a significant expansion in the market size of cardiovascular medical lasers. Projections indicate a surge from $0.31 billion in 2024 to $0.45 billion in 2025, reflecting a compound annual growth rate (CAGR)
Rising Prevalence Of Cardiovascular Disorders Fuels Growth In The Cardiovascular …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cardiovascular Devices Market Through 2025? In recent times, there has been a significant expansion in the cardiovascular devices market size. It is expected to surge from $73.14 billion in 2024 to $79.78 billion in 2025, reflecting a compound annual growth rate (CAGR)
Impact Of Increasing Cardiovascular Disease Patients On The Cardiovascular Infor …
The Cardiovascular Information System Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Cardiovascular Information System Market Size and Its Estimated Growth Rate? The cardiovascular information system market has seen strong growth in recent years. It will rise from $1.16 billion in 2024
Surge In Cardiovascular Diseases Fuels Growth Of Cardiovascular Digital Solution …
The Cardiovascular Digital Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiovascular Digital Solutions Market Size During the Forecast Period? The market size for cardiovascular digital solutions has been experiencing robust growth in the past few years. The forecast suggests it
Cardiovascular Devices Market - Heart-Centric Innovations: Elevating Cardiovascu …
Newark, New Castle, USA: The "Cardiovascular Devices Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiovascular Devices Market: https://www.growthplusreports.com/report/cardiovascular-devices-market/7791 This latest report researches the industry structure, sales, revenue,